4.6 Article

PIK3CB/p110 beta is a selective survival factor for glioblastoma

Related references

Note: Only part of the references are listed.
Article Oncology

Survival kinase genes present prognostic significance in glioblastoma

Robin T. Varghese et al.

ONCOTARGET (2016)

Review Oncology

Nonsurgical treatment of recurrent glioblastoma

O. Gallego

CURRENT ONCOLOGY (2015)

Article Chemistry, Multidisciplinary

Real-Time Visualization of Nanoparticles Interacting with Glioblastoma Stem Cells

Elliot S. Pohlmann et al.

NANO LETTERS (2015)

Review Biotechnology & Applied Microbiology

PI3K and cancer: lessons, challenges and opportunities

David A. Fruman et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Article Multidisciplinary Sciences

AcSDKP Regulates Cell Proliferation through the PI3KCA/Akt Signaling Pathway

Ping Hu et al.

PLOS ONE (2013)

Review Cell Biology

Emerging insights into the molecular and cellular basis of glioblastoma

Gavin P. Dunn et al.

GENES & DEVELOPMENT (2012)

Article Multidisciplinary Sciences

PTEN-deficient cancers depend on PIK3CB

Susan Wee et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Oncology

Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo

Peiyu Pu et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2006)

Review Oncology

Recent advances in the treatment of malignant astrocytoma

DA Reardon et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)